Enzymtherapie bij kanker
De controverse voorbij?

John Beard (1858-1924) vatte 100 jaar leden het idee op om kanker te behandelen met pancreasenzymen (Moss 2008a). Hij was een Schotse eerste klas embryoloog: de eerste om apoptose te beschrijven en hij ontdekte de rol van het corpus luteum (Moss 2008b). In 1902 stelde hij gelijkenissen vast tussen kankercellen en trofoblastcellen, de cellen die het chorion en de placenta vormen. Kanker was volgens hem het resultaat van verdwaalde trofoblastcellen, die op de verkeerde plaats en op het verkeerde tijdstip terug begonnen te delen. Zijn tweede ingeving was dat de pancreasenzymen van de foetus verantwoordelijk waren voor de regressie van het trofoblastweefsel, dat een natuurlijk proces is bij zwangerschap. De hypothese om kanker te behandelen met pancreasenzymen volgde snel.

Beste bezoeker, u heeft geen toegang.

Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.

U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!

Auteur

Joost Meeusen

Trefwoorden:

Figuren

Verschenen in

Referenties

  1. Elste AP, Petersen I. Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer. J Mol Histol. 2010 Apr;41(2-3):89-99

  1. Báez R, Lopes MT, Salas CE, Hernández M. In vivo antitumoral activity of stem pineapple (Ananas comosus) bromelain. Planta Med. 2007 Oct;73(13):1377-83

  2. Bailey KM, Wojtkowiak JW et al. Targeting the metabolic microenvironment of tumors. Adv Pharmacol. 2012;65:63-107

  3. Batkin S, Taussig SJ, Szekerezes J. Antimetastatic effect of bromelain with or without its proteolytic and anticoagulant activity. J Cancer Res Clin Oncol. 1988;114(5):507-8

  4. Beard J, Shaw-Mackenzie JA. The cancer problem and cancer research. The Lancet. 1905; 165(4250):385-386

  5. Beard J, Shaw-Mackenzie JA. The cancer problem and cancer research. The Lancet. 1905; 165(4250):385-386

  6. Beard J: The action of trypsin upon the living cells of Jensen's mouse tumor. Br Med J 1906, 4:140-141

  7. Beard J. Embryological aspects and etiology of carcinoma. The Lancet. 1902; 159(4112):1758 - 1761

  8. and its scientific basis (1911) Chatto & Windus, London

  9. Beuth J, Braun JM. Modulation of murine tumor growth and colonization by bromelaine, an extract of the pineapple plant (Ananas comosum L.). In Vivo. 2005 Mar-Apr;19(2):483-5

  10. Beuth J, Ost B, Pakdaman A et al. Impact of complementary oral enzyme application on the postoperative treatment of breast cancer patients: results of an epidemiological multicentre retrolective cohort study. Cancer Chemother Pharmacol. 2001;47:45-54

  11. Block KI. Enzymes and Cancer: A Look Toward the Past as We Move Forward. Integr Cancer Ther 2008 7: 223; DOI: 10.1177/1534735408327252

  12. Chabot JA, Tsai WY et al. Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. J Clin Oncol. 2010 Apr 20;28(12):2058-63

  13. Cohen LA, Aliaga C e tal. Oral enzyme therapy and experimental rat mammary tumor metastasis. Life Sciences. 1999; 65(24):2603-2614

  14. Cohen M, Bischof P. Factors regulating trophoblast invasion. Gynecol Obstet Invest. 2007;64(3):126-30

  15. Cole LA. hCG, the wonder of today's science. Reprod Biol Endocrinol. 2012 Mar 28;10:24

  16. Dale PS, Tamhankar CP et al. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother Pharmacol. 2001;47(suppl):S29-S34


  1. Desser L, Holomanova D et al. Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood. Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S10-5

  2. Desser L, Rehberger A et al. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology. 1993 Nov-Dec;50(6):403-7

  3. Desser L, Rehberger A et al. Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vitro. Cancer Biother. 1994 Fall;9(3):253-63

  4. Dörr W, Herrmann T. Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy: results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study. Strahlenther Onkol. 2007;183: 121-127

  5. 345-347

  6. Gonzalez JN. One Man Alone: An Investigation of Nutrition, Cancer, and William Donald Kelley (2010) New Spring Press

  7. Gonzalez NJ, Isaacs LL. Evaluation of pancreatic proteolytic enzyme treatment of adenocarcinoma of the pancreas, with nutrition and detoxification support. Nutr Cancer. 1999;33(2):117-24Levine MN. Conventional and complementary therapies: a tale of two research standards? J Clin Oncol. 2010 Apr 20;28(12):1979-81

  8. Gujral MS, Patnaik PM et al. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers. Cancer Chemother Pharmacol. 2001;47(suppl):S23-S28


  1. Hale LP, Haynes BF. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8 en Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol. 1992; 116:135-142

  2. Kaul R, Mishra BK et al. The role of Wobe-Mugos in reducing acute sequelae of radiation in head and neck cancers - a clinical phase-III randomized trial. Indian J Cancer. 1999;36:141-148


  1. Prevention of virus-induced mammary tumors by an orally active pancreas factor.

  2. Koskensalo S, Hagström J et al. Tumour-associated trypsin inhibitor TATI is a prognostic marker in colorectal cancer. Oncology. 2012;82(4):234-41

  3. Koivunen E, Ristimäki A et al. Tumor-associated Trypsin Participates in Cancer Cell-mediated Degradation of Extracellular Matrix. Cancer Res 1991;51:2107-2112

  4. Leipner J, Saller R. Systemic enzyme therapy in oncology: effect and mode of action. Drugs. 2000 Apr;59(4):769-80


  1. Louwen F, Muschol-Steinmetz C et al. A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget. 2012 Aug;3(8):759-73

  2. Martin T, Uhder K et al. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial. Radiother Oncol. 2002;65:17-22

  1. Matěj R, Mandáková P et al. Proteinase-activated receptor-2 expression in breast cancer and the role of trypsin on growth and metabolism of breast cancer cell line MDA MB-231. Physiol. Res. 56: 475-484, 2007

  1. Moss RW. Enzymes, trophoblasts, and cancer: the afterlife of an idea (1924-2008). Integr Cancer Ther. 2008 Dec;7(4):262-75.

  2. Moss RW. The life and times of John Beard, DSc (1858-1924). Integr Cancer Ther. 2008 Dec;7(4):229-51

  3. Novak JF, Trnka F. Proenzyme Therapy of Cancer. Anticancer Res. 2005; 25:1157-1178

  4. Novak JF, Trnka F et al. Trypsin/chymotrypsin and their respective zymogens inhibit tumor growth in vitro and in vivo. Proc Amer Assoc Cancer Res, Volume 47, 2006

  5. Popiela T, Kulig J, Hanisch J, Bock PR. Influence of complementary treatment with oral enzymes on patients with colorectal cancers: an epidemiological retrolective cohort study. Cancer Chemother Pharmacol. 2001;47:55-63

  6. Sakalova A, Bock PR, Dedik L, et al. Retrolective cohort study of an additive therapy with oral enzyme preparation in patients with multiple myeloma. Cancer Chemother Pharmacol. 2001;47:38-44

  7. Schaefer BA, Dooner C et al. Nutrition and Cancer: Further Case Studies Involving Salvestrol. Journal of Orthomolecular Medicine. 2010; 25(1):17-23

  8. Schaefer BA, Tan HL et al. Nutrition and Cancer: Salvestrol Case Studies. Journal of Orthomolecular Medicine. 2007; 22(4) E-pub

  9. Stauder G. Pharmacological effects of oral enzyme combinations. Cas Lek Cesk. 1995 Oct 4;134(19):620-4

  10. Taussig SJ, Szekerczes J, Batkin S. Inhibition of tumour growth in vitro by bromelain, an extract of the pineapple plant (Ananas comosus). Planta Med. 1985 Dec;(6):538-9

  11. Wald M, Olejár T et al. Proteinases reduce metastatic dissemination and increase survival time in C57Bl6 mice with the Lewis lung carcinoma. Life Sci. 1998;63(17):PL237-43

  12. Wald M, Olejár T, Sebková V et al. Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16. Cancer Chemother Pharmacol. 2001 Jul;47 Suppl:S16-22

  13. Wald M, Závadová E et al. Polyenzyme preparation Wobe-Mugos inhibits growth of solid tumors and development of experimental metastases in mice. Life Sci. 1998;62(3):PL43-8

  14. Wald M. Exogenous proteases confer a significant chemopreventive effect in experimental tumor models. Integr Cancer Ther 2008 7: 295 DOI: 10.1177/1534735408327036

  15. Retrospectief onderzoek naar de effectiviteit van de Moermantherapie bij kankerpatiënten (1991) Sdu Uitgeverij 's-Gravenhage

Gerelateerde artikelen

Naar een nieuw paradigma voor kanker?
Kankervrij
Hype alkalische voeding bij kanker onterecht
Een aspirientje tegen kanker?
Vasten